Last $172.81 USD
Change Today +0.72 / 0.42%
Volume 427.8K
ILMN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 1:30 PM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

5200 Illumina Way

San Diego, CA 92122

United States

Phone: 858-202-4500

Fax: 858-202-4766

investigate approximately 1,000,000 genetic markers targeting any species. Services In addition to the products that the company supplies to customers, it provides genotyping and whole genome sequencing services through its CLIA-certified, CAP-accredited laboratory. FastTrack Services The company offers genotyping services to academic institutions, biotechnology, and pharmaceutical customers. It also delivers sequencing services. Using its FastTrack services, customers could perform whole-genome sequencing projects (including phasing and long-read sequencing services) and microarray projects (including whole-genome association studies, DNA copy number studies, linkage analysis, fine mapping, and DNA methylation studies). Service Partnership Programs To complement the company’s own service capabilities, it has developed partnered programs, such as its Certified Service Providers (CSPro) and Illumina Genome Network (IGN), to create a worldwide network of Illumina technology-enabled service offerings that broaden its market reach. Illumina CSPro is a collaborative service partnership established between Illumina and genome centers and research laboratories to ensure the delivery of genetic analysis services. It provides an advantage for service providers, while also ensuring that customers would receive Illumina data quality and service. To become a CSPro provider, participating laboratories must complete a three-phased Illumina certification process. There are approximately 90 Illumina CSPro-certified organizations worldwide providing sequencing, genotyping, and gene expression services using its technologies and products. The IGN links researchers interested in conducting whole genome sequencing projects with institutes worldwide that possess the company’s next-generation sequencing technology. The IGN provides a dependable way to complete large sequencing projects. Members include British Columbia Cancer Agency’s Genome Sciences Centre; Cold Spring Harbor Laboratory; HudsonAlpha Institute for Biotechnology; Macrogen; the Northwest Genomics Center at the University of Washington; the New York Genome Center; Takara Bio; and Illumina’s own FastTrack Services. Individual Genome Sequencing The company’s Clinical Services Laboratory has been offering personal genome sequencing from its CLIA-certified, CAP-accredited laboratory using Illumina next-generation sequencing technology. It offers various individual sequencing options, including the TruGenome Undiagnosed Disease Test, which aids in the diagnosis of inherited diseases of a single-gene; the TruGenome Predisposition Screen, which evaluates carrier status and enables patient-physician discussions about managing risk for a pre-defined set of adult-onset conditions; and TruGenome Technical Sequence Data, which provides whole-genome sequencing services for situations where the physician is able to analyze and interpret whole-genome sequencing data. For each service, individuals are required to follow the company’s physician-mediated process, which involves pre-service consultation and informed consent that includes review of the information to be learned in the report. The final genome data is returned to the physician who then meets with the patient and discusses implications and possible actions based on the results. Principal Markets The company serves life sciences, reproductive and genetic health, oncology, enterprise informatics, and new and emerging markets. Marketing and Distribution The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region. In addition, in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and South Africa, the company sells its products and provides services to customers through distributors that specialize in life science products. Sales The company has sales offices located internationally throughout Europe, the Asia-Pacific region, and Brazil. Intellectual Property The company has an intellectual property portfolio, including as of February 1, 2014, ownership of, or exclusive li

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ILMN:US $172.81 USD +0.72

ILMN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alexion Pharmaceuticals Inc $168.89 USD +2.42
Avago Technologies Ltd $76.13 USD -0.14
Sigma-Aldrich Corp $103.82 USD -0.05
UCB SA €73.33 EUR -0.17
Vertex Pharmaceuticals Inc $89.82 USD +0.83
View Industry Companies
 

Industry Analysis

ILMN

Industry Average

Valuation ILMN Industry Range
Price/Earnings 100.0x
Price/Sales 13.9x
Price/Book 22.2x
Price/Cash Flow 93.7x
TEV/Sales 13.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ILLUMINA INC, please visit www.illumina.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.